𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of Pediatric Patients with Acute Group A Beta-Hemolytic Streptococccal Tonsillopharyngitis

✍ Scribed by B. Jakob-Sölder; C. Steininger; A. Eigentler; F. Allerberger

Publisher
Springer
Year
1998
Tongue
English
Weight
33 KB
Volume
17
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of osteosarcoma with ifosfamid
Treatment of osteosarcoma with ifosfamide: Comparison of response in pediatric patients with recurrent disease versus patients previously untreated: A pediatric oncology group study
✍ Harris, Michael B. ;Cantor, Alan B. ;Goorin, Allen M. ;Shochat, Stephen J. ;Ayal 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

## Abstract This study was designed to test if the activity of a phase II agent, ifosfamide, would have been underestimated if it was tested exclusively in a population of children and young adults with recurrent osteosarcoma. The response rate to ifosfamide was compared in patients younger than 30

Treatment of Czech children with acute l
Treatment of Czech children with acute lymphoblastic leukemia: A report of the Czech working group for pediatric hematology
✍ Starý, Jan ;Gajdoš, Petr ;Hrstková, Hana ;Blažek, Bohumír ;Slavík, Zdeněk ;Mihál 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Results in 258 children with acute lymphoblastic leukemia (ALL) treated in the Czech Republic between 1979 and 1983 according to in-house protocols demonstrated a dismal outcome. The complete remission (CR) rate was 82%, 3-year event free survival (EFS) 30% and overall survival 44%. The Czech Workin

Treatment intensity and outcome for chil
Treatment intensity and outcome for children with acute lymphocytic leukemia of standard risk. A pediatric oncology group study
✍ Jan van Eys; Daisilee Berry; William Crist; Ed Doering; Donald Fernbach; Jeanett 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 2 views

Four hundred thirty-four children, with good-risk acute lymphocytic leukemia (ALL), were assigned randomly to receive intensive or less intensive maintenance therapy with 6-mercaptopurine and methotrexate, plus vincristine and prednisone pulses in such a way that patients on treatment 1 had their le